NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
11/12/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 224 | ||
08/13/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 34 | ||
05/14/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 32 | ||
11/13/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 97 | ||
08/10/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 95 | ||
05/22/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 35 | ||
05/16/23 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB | 2 | ||
11/10/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 39 | ||
08/09/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 40 | ||
05/10/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 56 |